Rare diseases
Investigational molecules
Locations
201 Elliott Avenue West, 98119-4265, United States
Omeros Corp. supports clinical research in rare glomerular diseases affecting the kidney, with a focus on C3 glomerulopathy and idiopathic immune complex-mediated glomerulonephritis. The studies associated with this area examine immune-mediated renal injury and complement-driven inflammation.
These trials reflect interest in conditions where dysregulation of the complement system contributes to progressive renal damage.
Omeros Corp. runs clinical trials in conditions such as Thrombotic microangiopathy, Glomerulonephritis, Paroxysmal nocturnal haemoglobinuria, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
LithuaniaGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
